Literature DB >> 10430433

Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS?

A Tourbah1, O Gout, R Liblau, O Lyon-Caen, C Bougniot, M T Iba-Zizen, E A Cabanis.   

Abstract

OBJECTIVE: To describe clinical and MRI features of patients with a disease suggestive of CNS inflammation after hepatitis B vaccination.
METHODS: Eight patients with confirmed CNS inflammation occurring less than 10 weeks after hepatitis B vaccination are described. They received follow-up clinically and on MRI for a mean period of 18 months.
RESULTS: Clinical and MRI findings were compatible with acute disseminated encephalomyelitis. However, clinical follow-up, repeated MRI, or both showed the persistence of inflammatory activity, which makes this encephalitis more suggestive of MS than of acute disseminated encephalomyelitis.
CONCLUSION: The persistent inflammatory activity observed clinically and on MRI in these patients is comparable with that usually observed in MS. Epidemiologic studies are currently testing the hypothesis of a triggering role of hepatitis B vaccination in CNS demyelination.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430433     DOI: 10.1212/wnl.53.2.396

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

Review 1.  [Acute disseminated encephalomyelitis. Pathogenesis, diagnosis, treatment, and prognosis].

Authors:  O Stüve; S Nessler; H P Hartung; B Hemmer; H Wiendl; B C Kieseier
Journal:  Nervenarzt       Date:  2005-06       Impact factor: 1.214

2.  Autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA syndrome) in commercial sheep.

Authors:  Lluís Luján; Marta Pérez; Eider Salazar; Neila Álvarez; Marina Gimeno; Pedro Pinczowski; Silvia Irusta; Jesús Santamaría; Nerea Insausti; Yerzol Cortés; Luis Figueras; Isabel Cuartielles; Miguel Vila; Enrique Fantova; José Luis Gracia Chapullé
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 3.  Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?

Authors:  Maria Vadalà; Dimitri Poddighe; Carmen Laurino; Beniamino Palmieri
Journal:  EPMA J       Date:  2017-07-20       Impact factor: 6.543

4.  HBV vaccine and risk of developing multiple sclerosis: a systematic review and meta-analysis.

Authors:  Cristina Sestili; Inês Grazina; Giuseppe La Torre
Journal:  Hum Vaccin Immunother       Date:  2021-07-03       Impact factor: 4.526

5.  Central Demyelinating Diseases after Vaccination Against Hepatitis B Virus: A Disproportionality Analysis within the VAERS Database.

Authors:  Julie Mouchet; Bernard Bégaud
Journal:  Drug Saf       Date:  2018-08       Impact factor: 5.228

Review 6.  Hepatitis B vaccination and associated oral manifestations: a non-systematic review of literature and case reports.

Authors:  B Tarakji; N Ashok; R Alakeel; Sn Azzeghaibi; A Umair; S Darwish; Rs Mahmoud; E Elkhatat
Journal:  Ann Med Health Sci Res       Date:  2014-11

Review 7.  Vaccination in Multiple Sclerosis: Friend or Foe?

Authors:  Tobias Zrzavy; Herwig Kollaritsch; Paulus S Rommer; Nina Boxberger; Micha Loebermann; Isabella Wimmer; Alexander Winkelmann; Uwe K Zettl
Journal:  Front Immunol       Date:  2019-08-07       Impact factor: 7.561

8.  Improvement of advanced postvaccinal demyelinating encephalitis due to plasmapheresis.

Authors:  Andreas Rogalewski; Jörg Kraus; Martin Hasselblatt; Christoffer Kraemer; Wolf-Rüdiger Schäbitz
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

Review 9.  Acute disseminated encephalomyelitis: clinical and pathogenesis features.

Authors:  Farshid Noorbakhsh; Richard T Johnson; Derek Emery; Christopher Power
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

Review 10.  Post-vaccination encephalomyelitis: literature review and illustrative case.

Authors:  William Huynh; Dennis J Cordato; Elias Kehdi; Lynette T Masters; Chris Dedousis
Journal:  J Clin Neurosci       Date:  2008-10-30       Impact factor: 1.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.